New hope for IBS sufferers: allergy drug may beat standard treatment
Symptom relief
Recruiting now
This study tests whether ebastine, an allergy medication, works better than mebeverine, a common IBS drug, for reducing belly pain and improving overall symptoms. About 200 adults with non-constipated IBS will take one of the two drugs for 12 weeks. The goal is to see if ebastine…
Phase: PHASE3 • Sponsor: Guy Boeckxstaens • Aim: Symptom relief
Last updated May 02, 2026 15:01 UTC